Matrix proteoglycans: from molecular design to cellular function.
暂无分享,去创建一个
[1] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.
[2] A. Imberty,et al. Carbohydrates and glycoconjugates: Editorial overview , 1999 .
[3] R. Quatrano. Genomics , 1998, Plant Cell.
[4] R. Iozzo,et al. Decorin Activates the Epidermal Growth Factor Receptor and Elevates Cytosolic Ca2+ in A431 Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[5] R. Iozzo,et al. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.
[6] G. Yancopoulos,et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.
[7] T. Pawson,et al. The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.
[8] R. Iozzo,et al. Developmental expression of perlecan during murine embryogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[9] S. Stringer,et al. Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate* , 1997, The Journal of Biological Chemistry.
[10] E. Gundelfinger,et al. Sequence and chromosomal localization of the mouse brevican gene. , 1997, Genomics.
[11] M. Nugent,et al. Endothelial proteoglycans inhibit bFGF binding and mitogenesis , 1997, Journal of cellular physiology.
[12] L. Rosenberg,et al. Characterization of Epiphycan, a Small Proteoglycan with a Leucine-rich Repeat Core Protein* , 1997, The Journal of Biological Chemistry.
[13] M. Lyon,et al. The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.
[14] B. Calabretta,et al. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. , 1997, The Journal of clinical investigation.
[15] W. Halfter,et al. Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways , 1997, The Journal of comparative neurology.
[16] H. Kalthoff,et al. Biglycan gene promoter activity in osteosarcoma cells is regulated by cyclic AMP. , 1997, Biochemical and biophysical research communications.
[17] N. Grieshaber,et al. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. , 1997, Molecular biology of the cell.
[18] R. Iozzo,et al. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. , 1997, Cancer research.
[19] S. Coulter,et al. A Human-specific Polymorphism in the Coding Region of the Aggrecan Gene , 1997, The Journal of Biological Chemistry.
[20] E. Schönherr,et al. Expression of Small Extracellular Chondroitin/Dermatan Sulfate Proteoglycans Is Differentially Regulated in Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[21] M. Ruegg,et al. Agrin Binds to the Nerve–Muscle Basal Lamina via Laminin , 1997, The Journal of cell biology.
[22] J. J. Schwartz,et al. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? , 1997, The Journal of clinical investigation.
[23] Y. Kanwar,et al. Influence of glucose on murine metanephric development and proteoglycans: morphologic and biochemical studies. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[24] K. Kimata,et al. Alternative Splicing of the Unique “PLUS” Domain of Chicken PG-M/Versican Is Developmentally Regulated* , 1997, The Journal of Biological Chemistry.
[25] D. Noonan,et al. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA , 1997, Molecular and cellular biology.
[26] S. Dey,et al. Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. , 1997, Developmental biology.
[27] A. Friedl,et al. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. , 1997, The American journal of pathology.
[28] E. Schönherr,et al. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. , 1997, Archives of biochemistry and biophysics.
[29] U. Kishore,et al. Modular organization of carbohydrate recognition domains in animal lectins. , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[30] A. Malmström,et al. Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[31] P. Underwood,et al. THE EFFECT OF HUMAN ENDOTHELIAL CELL‐DERIVED PROTEOGLYCANS ON HUMAN SMOOTH MUSCLE CELL GROWTH , 1997, Cell biology international.
[32] J. Uitto,et al. Structural and Functional Characterization of the Human Perlecan Gene Promoter , 1997, The Journal of Biological Chemistry.
[33] J. Hassell,et al. Identification of Sites in Domain I of Perlecan That Regulate Heparan Sulfate Synthesis* , 1997, The Journal of Biological Chemistry.
[34] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[35] J. Couchman,et al. cDNA Cloning of the Basement Membrane Chondroitin Sulfate Proteoglycan Core Protein, Bamacan: A Five Domain Structure Including Coiled-Coil Motifs , 1997, The Journal of cell biology.
[36] T. Wight,et al. Selective Expression and Processing of Biglycan during Migration of Bovine Aortic Endothelial Cells , 1997, The Journal of Biological Chemistry.
[37] A. Barber,et al. Agrin accumulates in the brain microvascular basal lamina during development of the blood‐brain barrier , 1997 .
[38] R. Kucherlapati,et al. Characterization of human DSPG3, a small dermatan sulfate proteoglycan. , 1996, Genomics.
[39] S. Goodman,et al. Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves β1 integrins , 1996, European journal of immunology.
[40] M. Rüegg,et al. Diverse functions of the extracellular matrix molecule agrin , 1996 .
[41] A. Kumar,et al. D-glucose-induced dysmorphogenesis of embryonic kidney. , 1996, The Journal of clinical investigation.
[42] X. Chen,et al. The gene organization, chromosome location, and expression of a 55-kDa matrix protein (PRELP) of human articular cartilage. , 1996, Genomics.
[43] E. Hedbom,et al. Distinct Isoforms of Chicken Decorin Contain Either One or Two Dermatan Sulfate Chains* , 1996, The Journal of Biological Chemistry.
[44] M. Kunimatsu,et al. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[45] C. Peschle,et al. The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.
[46] R. Timpl,et al. Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan , 1996, FEBS letters.
[47] S. Grieshaber,et al. Developmental regulation of perlecan gene expression in aortic smooth muscle cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[48] T. Sasaki,et al. Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[49] U. Greferath,et al. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. , 1996, Development.
[50] A. Groffen,et al. Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells. , 1996, European journal of biochemistry.
[51] J. Uitto,et al. Identification of a Bimodal Regulatory Element Encompassing a Canonical AP-1 Binding Site in the Proximal Promoter Region of the Human Decorin Gene* , 1996, The Journal of Biological Chemistry.
[52] H. Larjava,et al. Human Granulation-tissue Fibroblasts Show Enhanced Proteoglycan Gene Expression and Altered Response to TGF-β1 , 1996, Journal of dental research.
[53] I. Campbell,et al. Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration , 1996, Cell.
[54] S. Shapiro,et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Templeton,et al. Posttranscriptional effects of glucose on proteoglycan expression in mesangial cells. , 1996, Metabolism: clinical and experimental.
[56] D. Heinegård,et al. 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. , 1996, Cancer research.
[57] Z. Werb,et al. Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[58] A. Hocking,et al. Recombinant Decorin Glycoforms , 1996, The Journal of Biological Chemistry.
[59] K. Oritani,et al. Identification of stromal cell products that interact with pre-B cells , 1996, The Journal of cell biology.
[60] D. Birk,et al. Differential expression of fibromodulin mRNA associated with tendon fibril growth: isolation and characterization of a chicken fibromodulin cDNA. , 1996, The Biochemical journal.
[61] U. Rauch,et al. Structural and Electron Microscopic Analysis of Neurocan and Recombinant Neurocan Fragments* , 1996, The Journal of Biological Chemistry.
[62] J. Scott. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. , 1996, Biochemistry.
[63] J. Fallon,et al. Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[64] E. Schleicher,et al. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin. , 1996, European journal of cell biology.
[65] E. Zycband,et al. Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendon. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[66] P. Maurel,et al. TAG-1/Axonin-1 Is a High-affinity Ligand of Neurocan, Phosphacan/Protein-tyrosine Phosphatase-ζ/β, and N-CAM* , 1996, The Journal of Biological Chemistry.
[67] H. Ungefroren,et al. Transcriptional Regulation of the Human Biglycan Gene* , 1996, The Journal of Biological Chemistry.
[68] N. Wahab,et al. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. , 1996, The Biochemical journal.
[69] M. Weber,et al. Atrial Natriuretic Peptide Inhibits Mitogen-activated Protein Kinase through the Clearance Receptor , 1996, The Journal of Biological Chemistry.
[70] C. Slater. Agrin signals at the junction , 1996, Nature.
[71] J. Bartek,et al. The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix. , 1996, Oncogene.
[72] J. Sanes,et al. Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant Mice , 1996, Cell.
[73] P. Distefano,et al. Agrin Acts via a MuSK Receptor Complex , 1996, Cell.
[74] P. Distefano,et al. The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo , 1996, Cell.
[75] J. A. Chapman,et al. Collagen fibril formation. , 1996, The Biochemical journal.
[76] P. Antonsson,et al. Amino‐terminal deletions in the decorin core protein leads to the biosynthesis of proteoglycans with shorter glycosaminoglycan chains , 1996, FEBS letters.
[77] John M. Whitelock,et al. The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.
[78] G. Conrad,et al. Molecular Cloning and Tissue Distribution of Keratocan , 1996, The Journal of Biological Chemistry.
[79] J. Couchman,et al. Perlecan and Basement Membrane-Chondroitin Sulfate Proteoglycan (Bamacan) Are Two Basement Membrane Chondroitin/Dermatan Sulfate Proteoglycans in the Engelbreth-Holm-Swarm Tumor Matrix (*) , 1996, The Journal of Biological Chemistry.
[80] P. Heitz,et al. Distribution of the large aggregating proteoglycan versican in adult human tissues. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[81] Y. Kaneda,et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.
[82] R. Iozzo,et al. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[83] E. Thonar,et al. Proteoglycans contain a 4.6 A repeat in muscular dystrophy corneas: x-ray diffraction evidence. , 1996, Biophysical journal.
[84] B. Kasinath,et al. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium , 1996, Journal of cellular physiology.
[85] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[86] P. Maurel,et al. Chondroitin sulfate proteoglycans in the developing central nervous system. I. Cellular sites of synthesis of neurocan and phosphacan , 1996, The Journal of comparative neurology.
[87] M. Rüegg. Agrin, laminin β2 (s-laminin) and ARIA: their role in neuromuscular development , 1996 .
[88] M. Mörgelin,et al. Inhibitory effects of PG‐H/aggrecan and PG‐M/versican on avian neural crest cell migration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[89] V. Hascall,et al. Proteoglycans and proteins in the extracellular matrix of mouse cumulus cell-oocyte complexes. , 1996, Archives of biochemistry and biophysics.
[90] M. Ruegg,et al. An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix , 1995, The Journal of cell biology.
[91] S. Orkin,et al. A Functional Initiator Element in the Human β-Globin Promoter (*) , 1995, The Journal of Biological Chemistry.
[92] K. Watanabe,et al. cDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican. , 1995, Biochemical and biophysical research communications.
[93] C. Garner,et al. Brevican, a Chondroitin Sulfate Proteoglycan of Rat Brain, Occurs as Secreted and Cell Surface Glycosylphosphatidylinositol-anchored Isoforms (*) , 1995, The Journal of Biological Chemistry.
[94] E. Ruoslahti,et al. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[95] K. Danielson,et al. The murine biglycan: complete cDNA cloning, genomic organization, promoter function, and expression. , 1995, Genomics.
[96] R. U. Margolis,et al. Chondroitin Sulfate and Chondroitin/Keratan Sulfate Proteoglycans of Nervous Tissue: Developmental Changes of Neurocan and Phosphacan , 1995, Journal of neurochemistry.
[97] D. Heinegård,et al. The Primary Structure of a Basic Leucine-rich Repeat Protein, PRELP, Found in Connective Tissues (*) , 1995, The Journal of Biological Chemistry.
[98] R. Mason,et al. Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. , 1995, Kidney international.
[99] J. Scott,et al. Extracellular matrix, supramolecular organisation and shape. , 1995, Journal of anatomy.
[100] J. Korenberg,et al. The Human Lumican Gene , 1995, The Journal of Biological Chemistry.
[101] J. Couchman,et al. Association of versican with dermal matrices and its potential role in hair follicle development and cycling. , 1995, The Journal of investigative dermatology.
[102] L. Siracusa,et al. Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13. , 1995, Genomics.
[103] Oldberg,et al. Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.
[104] A. Ljubimov,et al. Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[105] D. Beier,et al. Structure and chromosomal localization of the mouse neurocan gene. , 1995, Genomics.
[106] R. Timpl,et al. Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. , 1995, European journal of biochemistry.
[107] L. Vaughan,et al. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. , 1995, Development.
[108] R. Iozzo. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[109] T Skorski,et al. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[110] J. Cheng,et al. Structure of the human aggrecan gene: exon-intron organization and association with the protein domains. , 1995, The Biochemical journal.
[111] W. Halfter,et al. Identification of a Novel Alternatively Spliced Agrin mRNA That Is Preferentially Expressed in Non-neuronal Cells (*) , 1995, The Journal of Biological Chemistry.
[112] P. Bork,et al. The SEA module: A new extracellular domain associated with O‐glycosylation , 1995, Protein science : a publication of the Protein Society.
[113] R. Stallings,et al. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. , 1995, Genomics.
[114] K. Kimata,et al. Molecular cloning of the mouse osteoglycin-encoding gene. , 1995, Gene.
[115] R. Kokenyesi,et al. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. , 1995, Biochemical and biophysical research communications.
[116] S. Sugiyama,et al. Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence. , 1995, The Biochemical journal.
[117] J. Marcum,et al. Distribution of biglycan and its propeptide form in rat and bovine aortic tissue. , 1995, Journal of vascular research.
[118] J. Uitto,et al. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha , 1995, The Journal of Biological Chemistry.
[119] F. Maquart,et al. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. , 1995, The Biochemical journal.
[120] G. Waksman,et al. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. , 1995, Science.
[121] E. Schönherr,et al. Decorin-Type I Collagen Interaction , 1995, The Journal of Biological Chemistry.
[122] H. Larjava,et al. Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts. , 1995, The Journal of investigative dermatology.
[123] F. Matsui,et al. Distribution of a Brain‐specific Proteoglycan, Neurocan, and the Corresponding mRNA During the Formation of Barrels in the Rat Somatosensory Cortex , 1995, The European journal of neuroscience.
[124] E. Zycband,et al. Collagen fibrillogenesis in situ: Fibril segments undergo post‐depositional modifications resulting in linear and lateral growth during matrix development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[125] W. Halfter,et al. Agrin Is a Heparan Sulfate Proteoglycan (*) , 1995, The Journal of Biological Chemistry.
[126] R. Timpl,et al. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. , 1995, Matrix biology : journal of the International Society for Matrix Biology.
[127] G. Laurie,et al. Recombinant Domain III of Perlecan Promotes Cell Attachment through Its RGDS Sequence (*) , 1995, The Journal of Biological Chemistry.
[128] D. Zimmermann,et al. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. , 1994, The Journal of biological chemistry.
[129] M. Dours-Zimmermann,et al. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. , 1994, The Journal of biological chemistry.
[130] T Matsumoto,et al. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.
[131] A. Yayon,et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.
[132] Y. Yamada,et al. The structure of the rat aggrecan gene and preliminary characterization of its promoter. , 1994, The Journal of biological chemistry.
[133] R. Iozzo,et al. Abnormal expression of perlecan proteoglycan in metastatic melanomas. , 1994, Cancer research.
[134] L. Siracusa,et al. The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. , 1994, The Journal of biological chemistry.
[135] K. Ito,et al. Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. , 1994, The Journal of biological chemistry.
[136] M. Jalkanen,et al. Function of the syndecans--a family of cell surface proteoglycans. , 1994, Journal of cell science.
[137] R. Iozzo,et al. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. , 1994, The Biochemical journal.
[138] E. Ruoslahti,et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.
[139] M. Yamagata,et al. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. , 1994, Journal of cell science.
[140] D. Rowe,et al. Molecular basis of nanomelia, a heritable chondrodystrophy of chicken. , 1994, Matrix biology : journal of the International Society for Matrix Biology.
[141] P. Roughley,et al. Cartilage proteoglycans: Structure and potential functions , 1994, Microscopy research and technique.
[142] F. Deák,et al. Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan. , 1994, Genomics.
[143] R. Cassingena,et al. SV40 large-T oncogene inhibits transcription of perlecan-related proteoglycans but stimulates hyaluronan synthesis in a temperature-sensitive renal-tubule principal cell line. , 1994, The Journal of biological chemistry.
[144] C. Kozak,et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene , 1994, Nature Genetics.
[145] M. Fukuda. Cell surface and extracellular glycoconjugates , 1994 .
[146] D. Friedlander,et al. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth , 1994, The Journal of cell biology.
[147] R. U. Margolis,et al. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. , 1994, The Journal of biological chemistry.
[148] K Watanabe,et al. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. , 1994, The Journal of biological chemistry.
[149] R. Iozzo. Perlecan: a gem of a proteoglycan. , 1994, Matrix biology : journal of the International Society for Matrix Biology.
[150] John,et al. Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[151] D. Volpin,et al. Identification of a TGF-β Responsive Element in the Human Elastin Promoter , 1994 .
[152] L. Bruckner-Tuderman,et al. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis , 1994, Journal of Cell Biology.
[153] J. Hassell,et al. Molecular polymorphism of lumican during corneal development. , 1994, Investigative ophthalmology & visual science.
[154] R. Iozzo,et al. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[155] R. Iozzo,et al. Structural and functional characterization of the human decorin gene promoter. A homopurine-homopyrimidine S1 nuclease-sensitive region is involved in transcriptional control. , 1994, The Journal of biological chemistry.
[156] D. Heinegård,et al. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. , 1993, The Journal of biological chemistry.
[157] A. Plaas,et al. Biosynthetic mechanisms for the addition of polylactosamine to chondrocyte fibromodulin. , 1993, The Journal of biological chemistry.
[158] E. Edelman,et al. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. , 1993, Circulation research.
[159] N. Schwartz,et al. cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. , 1993, The Journal of biological chemistry.
[160] R. Pierce,et al. Alternate exon usage is a commonly used mechanism for increasing coding diversity within genes coding for extracellular matrix proteins. , 1993, Matrix.
[161] R. Iozzo,et al. Structural characterization of the complete human perlecan gene and its promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[162] G. Nicolson,et al. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production , 1993, International journal of cancer.
[163] A. Kikuchi,et al. Haemopoietic activity associated with biglycan like proteoglycan. , 1993, Biochemical and biophysical research communications.
[164] D. Heinegård,et al. Structure and deduced amino acid sequence of the human fibromodulin gene. , 1993, Biochimica et biophysica acta.
[165] T. Glant,et al. Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module. , 1993, The Journal of biological chemistry.
[166] T. Südhof,et al. Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[167] K. Ito,et al. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. , 1993, The Journal of biological chemistry.
[168] G. Conrad,et al. Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. , 1993, The Journal of biological chemistry.
[169] J. Hassell,et al. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.
[170] J. Hassell,et al. Perlecan gene expression precedes laminin gene expression during differentiation of F9 embryonal carcinoma cells , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.
[171] R. Timpl,et al. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. , 1993, The Journal of biological chemistry.
[172] X. Chen,et al. Assignment of the human aggrecan gene (AGC1) to 15q26 using fluorescence in situ hybridization analysis. , 1993, Genomics.
[173] S. Nakamura,et al. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[174] P. Roughley,et al. Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan. , 1993, The Biochemical journal.
[175] R. Butkowski,et al. Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans. , 1993, The Journal of biological chemistry.
[176] J. van den Born,et al. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. , 1993, Kidney international.
[177] E. Bonucci,et al. Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[178] R. U. Margolis,et al. Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules , 1993, The Journal of cell biology.
[179] M. Iruela-Arispe,et al. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. , 1992, Experimental cell research.
[180] J. Volanakis,et al. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.
[181] Vogel Kg,et al. The effects of transforming growth factor-beta and serum on proteoglycan synthesis by tendon fibrocartilage. , 1992, European journal of cell biology.
[182] J. McPherson,et al. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). , 1992, Genomics.
[183] E. Ruoslahti,et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.
[184] E. Qwarnstrom,et al. The role of proteoglycans in cell adhesion, migration and proliferation. , 1992 .
[185] P. Maurel,et al. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. , 1992, The Journal of biological chemistry.
[186] M. Linial,et al. Structure and chromosomal localization of the mammalian agrin gene , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[187] R. Timpl,et al. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. , 1992, European journal of biochemistry.
[188] J. Tímár,et al. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. , 1992, The American journal of pathology.
[189] A. Gressner,et al. Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors , 1992, Hepatology.
[190] M. Rocchi,et al. Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. , 1992, Genomics.
[191] D. Birk,et al. beta-D xyloside alters dermatan sulfate proteoglycan synthesis and the organization of the developing avian corneal stroma. , 1992, Development.
[192] J. Turnbull,et al. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.
[193] E. Ruoslahti,et al. Hyaluronate binding properties of versican. , 1992, The Journal of biological chemistry.
[194] G. R. Dodge,et al. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. , 1992, The Journal of biological chemistry.
[195] H. Olsen,et al. Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene , 1992, Molecular and cellular biology.
[196] R. Iozzo,et al. Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains. , 1992, Matrix.
[197] J. Vergnes,et al. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. , 1992, The Journal of biological chemistry.
[198] K. Tryggvason,et al. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor , 1992, The Journal of cell biology.
[199] D. Noonan,et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. , 1991, The Journal of biological chemistry.
[200] D. Rowe,et al. Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. , 1991, The Biochemical journal.
[201] J. Esko. Genetic analysis of proteoglycan structure, function and metabolism. , 1991, Current opinion in cell biology.
[202] E. Schönherr,et al. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.
[203] M. Young,et al. Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization. , 1991, The Journal of biological chemistry.
[204] A. Bassols,et al. Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts. , 1991, Biochimica et biophysica acta.
[205] I. Kovalszky,et al. Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. , 1991, Genomics.
[206] B. Olwin,et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.
[207] H. Larjava,et al. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. , 1991, The Journal of biological chemistry.
[208] D. Heinegård,et al. The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TFG-beta. , 1991, Matrix.
[209] T. Imamura,et al. Contact with basement membrane heparan sulfate enhances the growth of transformed vascular endothelial cells, but suppresses normal cells. , 1991, Cell structure and function.
[210] R. Ádány,et al. Hypomethylation of the decorin proteoglycan gene in human colon cancer. , 1991, The Biochemical journal.
[211] L. Sandell,et al. Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procore protein. , 1991, The Journal of biological chemistry.
[212] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[213] K. Doege,et al. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. , 1991, The Journal of biological chemistry.
[214] A. Plaas,et al. Identification of the keratan sulfate attachment sites on bovine fibromodulin. , 1990, The Journal of biological chemistry.
[215] I. Kovalszky,et al. Fatty acylation of heparan sulfate proteoglycan from human colon carcinoma cells. , 1990, The Journal of biological chemistry.
[216] I. Kovalszky,et al. Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells. , 1990, The Journal of biological chemistry.
[217] J. Couchman,et al. Basement membrane chondroitin sulfate proteoglycans: localization in adult rat tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[218] R. Ádány,et al. Altered methylation of versican proteoglycan gene in human colon carcinoma. , 1990, Biochemical and biophysical research communications.
[219] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[220] R. Ádány,et al. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. , 1990, The Journal of biological chemistry.
[221] J. A. McBain,et al. Phorbol esters activate proteoglycan metabolism in human colon cancer cells en route to terminal differentiation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[222] M. Klemsz,et al. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.
[223] E. Ruoslahti,et al. Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis. , 1990, The Journal of biological chemistry.
[224] D. Rifkin,et al. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. , 1990 .
[225] O. Mcbride,et al. Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively. , 1990, Genomics.
[226] S. J. Courtois,et al. Nuclear factor-I and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-activate the human growth hormone gene , 1990, Nucleic Acids Res..
[227] J. Sanes,et al. Primary sequence of a motor neuron-selective adhesive site in the synaptic basal lamina protein s-laminin , 1989, Cell.
[228] E. Ruoslahti,et al. Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.
[229] D. Heinegård,et al. A collagen‐binding 59‐kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG‐S1 and PG‐S2 (decorin). , 1989, The EMBO journal.
[230] R. Tjian,et al. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.
[231] L. Rosenberg,et al. The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. , 1989, The Journal of biological chemistry.
[232] M. Young,et al. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.
[233] R. Iozzo. Presence of unsulfated heparan chains on the heparan sulfate proteoglycan of human colon carcinoma cells. Implications for heparan sulfate proteoglycan biosynthesis. , 1989, The Journal of biological chemistry.
[234] R. Iozzo,et al. Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications. , 1989, Archives of biochemistry and biophysics.
[235] Y. Courtois,et al. Specific binding of basic fibroblast growth factor to basement membrane‐like structures and to purified heparan sulfate proteoglycan of the EHS tumor , 1988, Journal of cellular physiology.
[236] E. Ruoslahti,et al. Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation , 1988, Nature.
[237] J. Heino,et al. Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein. , 1988, The Biochemical journal.
[238] D. E. Yorde,et al. Acetylcholine receptor-aggregating proteins are associated with the extracellular matrix of many tissues in Torpedo , 1988, The Journal of cell biology.
[239] T. Dexter,et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.
[240] M. Sporn,et al. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.
[241] D. Ingber,et al. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.
[242] G. Ruben,et al. Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. , 1987, The Journal of biological chemistry.
[243] T. Koob,et al. Characterization and interactions of a fragment of the core protein of the small proteoglycan (PGII) from bovine tendon. , 1987, Biochemical and biophysical research communications.
[244] J. Trotter,et al. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.
[245] E. Ruoslahti,et al. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[246] P. Scott,et al. A role for disulphide bridges in the protein core in the interaction of proteodermatan sulphate and collagen. , 1986, Biochemical and biophysical research communications.
[247] R. Iozzo,et al. Biosynthesis of proteoglycans by rat embryo parietal yolk sacs in organ culture. , 1986, The Journal of biological chemistry.
[248] R. Timpl,et al. Immunological characterization of basement membrane types of heparan sulfate proteoglycan. , 1985, The EMBO journal.
[249] V. Hascall,et al. Defective processing of keratan sulfate in macular corneal dystrophy. , 1984, The Journal of biological chemistry.
[250] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[251] H. Kleinman,et al. Regulation of type I collagen fibril assembly by link protein and proteoglycans. , 1984, Collagen and related research.
[252] Y. Kanwar,et al. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[253] J. Scott,et al. Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. , 1981, The Biochemical journal.
[254] M. Farquhar,et al. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion , 1980, The Journal of cell biology.
[255] A. Clowes,et al. Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.
[256] B. Toole. Solubility of Collagen Fibrils formed in vitro in the Presence of Sulphated Acid Mucopolysaccharide-protein , 1969, Nature.
[257] B. Toole,et al. The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. , 1968, The Biochemical journal.
[258] A. Horwich,et al. Structure and function in GroEL-mediated protein folding. , 1998, Annual review of biochemistry.
[259] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[260] P. Robbins,et al. Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. , 1998, Annual review of biochemistry.
[261] E. Cabib,et al. Role of small G proteins in yeast cell polarization and wall biosynthesis. , 1998, Annual review of biochemistry.
[262] B. Stillman,et al. The DNA replication fork in eukaryotic cells. , 1998, Annual review of biochemistry.
[263] F. Eckstein,et al. Modified oligonucleotides: synthesis and strategy for users. , 1998, Annual review of biochemistry.
[264] V. Schramm. Enzymatic transition states and transition state analog design. , 1998, Annual review of biochemistry.
[265] J. Workman,et al. Alteration of nucleosome structure as a mechanism of transcriptional regulation. , 1998, Annual review of biochemistry.
[266] M. W. Young. The molecular control of circadian behavioral rhythms and their entrainment in Drosophila. , 1998, Annual review of biochemistry.
[267] R. C. Dickson,et al. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. , 1998, Annual review of biochemistry.
[268] A. Frankel,et al. HIV-1: fifteen proteins and an RNA. , 1998, Annual review of biochemistry.
[269] H. Lipshitz,et al. RNA localization in development. , 1998, Annual review of biochemistry.
[270] I. Mattaj,et al. Nucleocytoplasmic transport: the soluble phase. , 1998, Annual review of biochemistry.
[271] N. Pace,et al. Ribonuclease P: unity and diversity in a tRNA processing ribozyme. , 1998, Annual review of biochemistry.
[272] R. Iozzo,et al. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.
[273] R. Timpl,et al. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. , 1997, European journal of biochemistry.
[274] Y. Yamaguchi. Brevican: a major proteoglycan in adult brain. , 1996, Perspectives on developmental neurobiology.
[275] A. Plioplys,et al. Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome. , 1995, Neuropsychobiology.
[276] P. Roughley,et al. Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.
[277] R. U. Margolis,et al. Aggrecan-versican-neurocan family proteoglycans. , 1994, Methods in enzymology.
[278] D. Noonan,et al. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. , 1993, Kidney international.
[279] Bostjan Kobe,et al. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats , 1993, Nature.
[280] R. Iozzo,et al. The human decorin gene: intron-exon organization, discovery of two alternatively spliced exons in the 5' untranslated region, and mapping of the gene to chromosome 12q23. , 1993, Genomics.
[281] D. Carson,et al. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. , 1993, Developmental biology.
[282] A. Woods,et al. Structure and Biology of Pericellular Proteoglycans , 1993 .
[283] D. Lane,et al. Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.
[284] R. Stevens,et al. Regulation of the gene that encodes the peptide core of heparin proteoglycan and other proteoglycans that are stored in the secretory granules of hematopoietic cells. , 1992, Advances in experimental medicine and biology.
[285] A. Plaas. Fibromodulin. A Perspective on Function. , 1992 .
[286] J. Spring,et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. , 1992, Annual review of cell biology.
[287] J. van den Born,et al. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. , 1992, Kidney international.
[288] L. Kjellén,et al. Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.
[289] M. Bernfield,et al. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. , 1990, American journal of respiratory cell and molecular biology.
[290] G. Holmes,et al. An 8-year experience with depth electrodes in the evaluation of ablative seizure surgery candidates. , 1990, Stereotactic and functional neurosurgery.